How to identify patients with vulnerable plaques

Section of Cardiology, Baylor College of Medicine
Diabetes Obesity and Metabolism (Impact Factor: 6.36). 11/2007; 10(10):824-33. DOI: 10.1111/j.1463-1326.2007.00812.x
Source: PubMed


Multiple strategies are available for clinicians to identify patients at high risk for cardiovascular events. Two commonly discussed strategies are the identification of vulnerable plaques and the identification of vulnerable patients. The strategy of identifying vulnerable patients is less invasive, easy to implement and not restricted primarily to one vascular bed (e.g. coronary or cerebral). This review discusses the utility as well as the limitations of global risk assessment tools to identify such patients. The utility of biomarkers [C-reactive protein, lipoprotein-associated phospholipase A(2) and lipoprotein(a)] and non-invasive measures of atherosclerosis burden (coronary artery calcium scores, carotid intima-media thickness and ankle-brachial index) in identifying patients at high risk for cardiovascular events are also discussed.

4 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Atherosclerotic cardiovascular disease is the leading cause of morbidity and mortality in the Western world. The escalation in global prevalence of abdominal adiposity and its associated metabolic risk factors has fueled speculation that cardiovascular disease will become the leading cause of mortality worldwide by 2020 (1). Increasing interest has focused on the development of new systemic biomarkers to assist in the prediction of cardiovascular risk. This should facilitate more effective use of therapeutic strategies developed for cardiovascular prevention.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Inflammation plays a key role in the pathogenesis of atherosclerosis. Understanding the process of inflammation as it pertains to atherosclerosis has provided researchers with multiple opportunities to identify novel markers for use in cardiovascular disease management. This article discusses the inflammatory cascade as it pertains to atherosclerosis and some of the well-studied markers of inflammation. It also discusses the limitations of current risk stratification models and characteristics of a good biomarker.
    Current Atherosclerosis Reports 05/2008; 10(2):164-70. DOI:10.1007/s11883-008-0024-0 · 3.42 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Inflammation is a complex process that allows elimination of tissular damaging agents and thus facilitates wound repair. Persistance of a damaging agent or the incapacity to resolve the inflammatory state leads to chronic homeostatic deregulation with putative incidence on morbidity and mortality. Atherosclerosis is an inflammatory state of blood vessels which origins are multifactorial. Hypertension and the infectious state represent classical and emerging factors of atherosclerosis development, respectively. The innate immune response takes place in the initial steps of inflammation, and represents the first cellular line of defense against danger signals. The goal of this thesis is to examine the pro- inflammatory roles of the IkB kinases (IKK) and the IKK-related kinases, which are essential innate immune response protein kinases. IKK and IKK form, toghether with NEMO/IKK, the IKK complex. This complex is responsible of the phosphorylation of the inhibitor of NF-B, IB, a process that leads to its degradation and NF-B release. By immunoprecipitation of NEMO and assessment of the IKK complex activity in vitro, we show that the vasoactive peptide angiotensin II (AngII) induces IKK phosphotransferase activity in vascular smooth muscle cells (VSMC). The use of RNA interference (RNAi) against IKK reveals that this kinase is responsible for p65/RelA phosphorylation. AngII modulation of NF-B is atypical since it does not modulate IB. Moreover, the use of pharmacological inhibitors shows that p65 induction is independent of both MEK-ERK- RSK and PI3K pathways, and that it does not involve EGF receptor transactivation. IKK- related kinases Tank-binding kinase 1 (TBK1) and IKK-i are known to be induced by bacterial and viral infections. These kinases are able to phosphorylate directly interferon regulatory factor (IRF)-3 transcription factor. Human cytomegalovirus (HCMV) seropositivity was shown to be linked to atherosclerosis development. We show that TBK1 activity is induced in HCMV-infected VSMC. RNAi directed against TBK1 and IKK-i reveals that both kinases are required for IRF-3 activation. The use of a VSMC line that express a dominant negative version if IRF-3 shows that this transcription factor is involved iii in the induction of RANTES and IP-10 chemokines, as assessed by RT-PCR. In addition, IKK-related kinases were recently shown to be implicated in oncogenic transformation. TBK1 was also shown to be pro-angiogenic. Angiogenesis is known to be regulated by the hypoxic response, a common condition of inflammatory processes. Hypoxia-inducible factor (HIF)-1 is a transcription factor that modulates angiogenesis, inflammation and cell survival. We show with the use of Tbk1 and Ikbke -/- cells combined with the use of a lentiviral approach that TBK1 is specifically involved in HIF-1 translational induction under hypoxic stress. We also show that TBK1 expression is enhanced under theses conditions, and that this kinase modulates the phosphorylation of ERK, RSK, Akt and TSC1. In conclusion, the results presented in this thesis show that the IKK and IKK-related kinases are both pro-inflammatory, and exert their actions by distinct mechanisms.
    12/2010, Degree: Ph.D., Supervisor: Marc Servant